The Trump administration has courted at least $3 trillion in investment and trade commitments since Trump's inauguration.

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox ...

Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.

In today's trading context, the average open interest for options of Eli Lilly stands at 500.96, with a total volume reaching 3,543.00. The accompanying chart delineates the progression of both ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

A major pharmaceutical company that has invested heavily in North Carolina is planning multiple new factories in the U.S. STORY HIGHLIGHTS Eli Lilly plans $27 billion U.S. expansion, will create ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Volume & Open Interest Trends In terms of liquidity and interest, the mean open interest for Eli Lilly options trades today is 402.8 with a total volume of 21,398.00. In the following chart ...

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on during any economic environment. This is because patients need their ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

Eli Lilly is expanding the supply and cutting ... (Shelby Knowles/Bloomberg via / Getty Images) "Every major medical organization and establishment recognizes obesity as a chronic disease, yet ...